CP and COVID-19: Since CP is generally administered within the first week of symptoms and the IgG half-life in circulation is 10 to 21 days, we may assume that even with the presence of considerable exogenous COVID-19 antibodies in circulation, the index COVID-19 antibody levels were still lower in the CP group, possibly indicating deterioration in endogenous antibody production [19].